Oliver Reinberg analyst KEPLER CHEUVREUX

Currently out of the existing stock ratings of Oliver Reinberg, 2 are a HOLD (40%), 3 are a BUY (60%).

Oliver Reinberg

Work Performance Price Targets & Ratings Chart

Analyst Oliver Reinberg, currently employed at KEPLER CHEUVREUX, carries an average stock price target met ratio of 33.33% that have a potential upside of 5.59% achieved within 11 days.

Oliver Reinberg’s has documented 10 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on QGEN, Qiagen NV at 14-Jul-2021.

Wall Street Analyst Oliver Reinberg

Analyst best performing recommendations are on QGEN (QIAGEN NV).
The best stock recommendation documented was for QGEN (QIAGEN NV) at 11/14/2019. The price target of $36.31 was fulfilled within 1 day with a profit of $2.14 (6.26%) receiving and performance score of 62.63.

Average potential price target upside

QGEN Qiagen NV FMS Fresenius Medical Care

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 05-Nov-2021

$47

$3.67 (8.47%)

$46

15 days ago
(09-Sep-2026)

6/8 (75%)

$4.5 (10.59%)

648

Buy Since 18-Jun-2024

$50

$6.67 (15.39%)

$45

1 months 17 days ago
(07-Aug-2026)

1/4 (25%)

$7.7 (18.20%)

581

Hold Since 29-Apr-2026

$40

$-3.33 (-7.69%)

$38

1 months 17 days ago
(07-Aug-2026)

5/6 (83.33%)

$-2.3 (-5.44%)

108

Hold Since 23-Jun-2026

$42

$2.59 (6.57%)

$48

3 months 1 days ago
(23-Jun-2026)

3/4 (75%)

$4.8 (12.90%)

614

Hold Since 23-Jun-2026

$42

$2.59 (6.57%)

$48

3 months 1 days ago
(23-Jun-2026)

6/9 (66.67%)

$4.8 (12.90%)

430

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Oliver Reinberg?

On 2019

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?